Joseph Trebley

Joseph Trebley has a diverse work experience with a focus in the biotech and pharmaceutical industries. Joseph is currently the CEO of Scioto Biosciences, Inc since 2017. Prior to this, they served as the President/CEO of Monon Bioventures, LLC starting in 2015. Joseph'srole involved working with scientists and physicians to turn discoveries into investable assets. Joseph also has experience as a President's Advisory Council Member at Wabash College since 2014, as a Board Director at the National Association of Wabash Men since 2013, and as a Board Member at the Indianapolis Association of Wabash Men from 2013 to 2016. Joseph also served as the Head of Startup Support and Promotion at Indiana University Research and Technology Corporation from 2011 to 2016. Joseph has held various leadership roles at Wabash College Board of Trustees, Purdue Research Foundation, Kylin Therapeutics, Inc., and Kylin Therapeutics from 2008 to 2013.

Joseph Trebley attended Rushville Consolidated High School from 1993 to 1997. After completing high school, they pursued a degree in Medicinal Chemistry and Molecular Pharmacology at Purdue University, where they earned a PhD. Additionally, they studied Chemistry at Wabash College, although the specific dates of attendance are not provided.